The trademark application RADLOBE was filed by NEQSGEN LLC, a Limited Liability Company (the "Applicant"). The application was published for oppositions on November 2, 2021, and it was registered by office on February 9, 2022 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and professional address of the trademark registration was recorded on June 26, 2023.
Goods And Services
The mark was filed in class 44 with following description of goods:
Medical treatment of cancer
Medical procedure to destroy cancer cells
Therapeutic radiological services
Radiation oncology services
Medical services
Medical services in the field of radiation therapy delivered internally or externally
Medical services in the nature of radiotherapy treatment to destroy cancer cells
Medical services in the nature of arterial embolization to destroy cancer cells
Medical services in the nature of radioembolization treatment to destroy cancer cells
Medical services in the nature of radiotherapy to convert cancerous tumors from unresectable to resectable
Medical services to induce growth of liver tissue
Medical services to convert cancerous tumors from inoperable to operable
Medical services to induce liver hypertrophy
Medical services as neoadjuvant to surgical resection